Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jordan T. Ewald
Observed name:
Jordan Ewald
Institutions:
University of Iowa,
University of Iowa Holden Comprehensive Cancer Center
Observed institutions:
University of Iowa,
University of Wisconsin–Madison,
University of Iowa Hospitals and Clinics,
University of Iowa Holden Comprehensive Cancer Center
ORCID:
0009-0006-9579-2451
Observed ORCID:
0009-0006-9579-2451
OpenAlex ID:
A5072891393
Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth
2024
·
Spenser S. Johnson
, Dijie Liu
, et al.
·
Cancer Biology & Therapy
·
23
Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers
2023
·
Melissa A. Fath
, Dijie Liu
, et al.
·
Radiation Research
·
16
PDF
Targeting CXCR4 with 212Pb/203Pb-Pentixather Significantly Increases Overall Survival in Small Cell Lung Cancer
2025
·
Keegan A. Christensen
, Melissa A. Fath
, et al.
·
Radiation Research
·
6
Inflammatory Biomarker Profiles in Very Preterm Infants within the Context of Preeclampsia, Chorioamnionitis, and Clinically Diagnosed Postnatal Infection
2023
·
Jordan T. Ewald
, Baiba Steinbrekera
, et al.
·
Pediatric Reports
·
3
PDF
Abstract 5034: Targeting CXCR4 and thioredoxin reductase in high grade neuroendocrine tumors and neuroendocrine carcinomas
2023
·
Melissa A. Fath
, Dijie Liu
, et al.
·
Cancer Research
·
1
Targeting CXCR4 and Thioredoxin Reductase in High Grade Neuroendocrine Tumors & Neuroendocrine Carcinomas
2023
·
Melissa Fath
, Doug Spitz
, et al.
·
Free Radical Biology and Medicine
Show more works
View as search
Works count:
6
Citation count:
49
H-index:
3
I10-index:
2
Year
Topic
Type